Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04673448
Title Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

pancreatic cancer

ovarian cancer

breast cancer

fallopian tube cancer

peritoneum cancer

Therapies

Dostarlimab + Niraparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.